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Abstract 
In this present study, we have analyzed one cytokine, interleukin-10 (IL-10), that plays a pivotal role in patients with 
chronic heart failure. For this purpose, a novel capacitance substrate, based on hafnium oxide (HfO2) grown by 
Atomic Layer Deposition on silicon, was applied to study the interaction between IL-10 with the corresponding 
antibody. HfO2 has been functionalized using an aldehyde monolayer, to directly immobilize the anti-human IL-10 
monoclonal antibody. The interaction between antibody-antigen (Ab-An), was characterized by fluorescence 
patterning and electrochemical impedance spectroscopy (EIS). The preliminary results for fluorescence patterning, 
demonstrated bio-recognition of the recombinant protein, while Nyquist plots showed variation when we changed the 
concentration from 1-10 ng/mL. This demonstrated that the developed biosensor was sensitive to the detection of IL-
10. 
 
© 2011 Published by Elsevier Ltd. 
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1. Introduction 
Cardiovascular diseases are a predominant cause of mortality in developed countries. Post-operative death  
due to cardiac surgery can be expressed by high elevated levels of varying cytokines and immune cells. 
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This fatal acute rejection can be determined by measuring specific biomarkers that provide clinical 
inflammation in both cellular and biochemical events. The anti-inflammatory cytokine, interleukin-10, 
(IL-10) contributes to this process when patients experience a cytokine storm [1]. 
  Hafnium oxide (HfO2), presents an alternative substrate to silicon dioxide, due to its high thermal 
stability, and high dielectric constant, when compared to silicon [2,3]. This high dielectric constant, 
requires no surface activation of hafnium oxide, and thus differs upon silicon, where piranha activation is 
a requirement for hydroxyl group formation. 
 
 
Fig. 1. Surface activation with triethoxysilane aldehyde (TEA) on hafnium oxide. 
 
  Immobilization of antibodies onto the immunosensor surface is a requirement, for the detection and 
analysis of bio-recognition processes [4,5]. By activation with triethoxysilane aldehyde (TEA), antibodies 
can be covalently bonded to a substrate surface, without additional activation steps that may affect the 
activity of the antibody [6]. 
  On activation of these surfaces, microcontact printing is a rapid technique that enables pattern transfer 
[7]. Fabrication of a polydimethylsiloxane (PDMS) stamp produced by soft-lithography, creates a pattern 
that can transfer biomolecules, over a large surface area on the printed substrate. These biomolecules are 
physisorbed onto the PDMS stamp, and transferred by conformal contact with the substrate, to form a 
biolayer. Application of a fluorescent biomarker, subsequently, denotes the Ab-An-Ab complex due to 
the visible fluorescent pattern. 
  In this research, we present a novel capacitance substrate of hafnium oxide (HfO2) where the surface has 
been functionalised with TEA. We also include TEA activation results of silicon dioxide, silicon nitride 
and aluminium oxide for comparison. This activation enables direct antibody bonding where no other 
reagents were required. 
2. Method 
A self-assembled monolayer of 11-(triethoxysilyl)undecanal was activated onto HfO2 surfaces, by vapor-
phase for 1 hr. This formulated the aldehyde (CHO) groups. Afterwards, the substrates were heated in an 
oven at 90°C for 1 hr. The substrates were then rinsed in ethanol, and dried with nitrogen. Using a 
positive 10 μm PDMS stamp, the anti-human IL-10 monoclonal antibody (10 μg/mL) was incubated for 
10 min, and then dried with nitrogen. By μCP, the PDMS stamp was brought into contact with the 
aldehyde activated substrate surface (10 min). Non-functionalised areas from the PDMS stamp were 
EORFNHGLQDVROXWLRQRIĮ-Methoxy-Ȧ-amino poly(ethylene glycol) (PEG-NH2) (1 mM) in triethylamine 
for 30 min, to prevent non-specific binding. The sample was then incubated with the rh IL-10 (0.25 
μg/mL) for 1 hr. Finally, the Ab-An-Ab bio-recognition was formulated, with the incubation of anti-
human IL-10 fluorescein monoclonal antibody (2.5 μg/mL) for 1 hr. 
3. Results 
Contact angles using deionised water demonstrated a higher hydrophilic nature on cleaned SiO2 and Si3N4 
substrates, in comparison to Al2O3 and HfO2. Both the latter contain higher dielectric constants than 
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silicon, while silicon substrates require piranha activation to ensure hydroxyl groups are present on the 
surface. By vapor-phase with TEA, the angles on all four substrates increase in hydrophobicity, due to the 
formation of aldehyde groups (Table 1). 
 
Table 1. Contact angles of cleaned substrates followed by oxygen and TEA activation. 
 
 
 
  The functionality of the immobilised receptor by the fluorescent pattern, visible in Fig. 2, shows the Ab-
An-Ab bio-recognition. The labelled fluorescent tags, formulate 10 μm positive structures, where non-
printed regions have been blocked with PEG-NH2. 
 
 
Fig. 2. Fluorescent image of IL-10 Ab-An-Ab recognition on HfO2, using a positive 10 μm PDMS stamp. After 
formation of the -CHO layer, IL-10 Ab was microcontact printed onto the surface, blocked with PEG-NH2, then 
incubated with the rh IL-10, followed by the IL-10 Ab tagged with fluorescein. 
  The interaction between antibody and antigen was also analysed by EIS. Primary results have indicated 
a distinction between the formation of the -CHO layer onto the HfO2 substrate, when compared to bare 
HfO2. By covalent bonding of the antibody onto the surface, we followed the detection of the 
recombinant protein by Nyquist plots (Fig. 3). With the incubation of the antigen to form an Ab-An 
complex, the substrate shows a variation and shift of impedance, with detectable concentrations ranging 
from 1-10 ng/mL. Though concentrations are within the ng/mL range, we aimed to ensure primarily that 
HfO2 was capable of modification. Future applications will concentrate on the development of biosensors 
based on field-effect transistors (FETs) using HfO2 as a gate. 
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Fig. 3. Nyquist plot demonstrating detection of varying rh IL-10 concentrations in comparison with IL-10 Ab. EIS 
measurements were carried out in PBS using the conditions: Frequency range from 50 mHz to 100 KHz, AC 
amplitude voltage at 25 mV and DC amplitude voltage at -100 mV. 
4. Conclusion 
In this work, we have achieved direct patterning of anti-human IL-10 monoclonal antibodies, onto HfO2 
grown by Atomic Layer Deposition on silicon, that have been activated with aldehyde groups. By μCP, 
the patterned antibodies have detected the recombinant human protein, as observed by fluorescence. EIS 
has shown that detection can be made with varying protein (IL-10) concentrations, though at this 
preliminary stage, analysis of the recombinant protein was acquired within the ng/mL range to ensure that 
detection was possible.  Silicon substrates have been used extensively in microelectronic applications. By 
application of HfO2, a novel type of capacitance biosensor can be fabricated for biosensor applications. 
Future experiments are on-going to analyse within the pg/mL range that will establish detectable 
concentrations. This will include sensitivity and selectivity that is attributable to non-specific binding of 
inactive proteins. 
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